Premium
GSK ‐3: A key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced AMPA to NMDA throughput
Author(s) -
Zarate Carlos A,
MachadoVieira Rodrigo
Publication year - 2016
Publication title -
bipolar disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.285
H-Index - 129
eISSN - 1399-5618
pISSN - 1398-5647
DOI - 10.1111/bdi.12452
Subject(s) - mental health , library science , medicine , gerontology , psychiatry , computer science